F19.16
Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.16 refers to a specific mental health condition characterized by the misuse of various psychoactive substances leading to a lasting impairment in memory. This disorder involves chronic substance abuse that results in persistent amnestic symptoms, impacting an individual's ability to remember recent and past events. Recognizing the signs and understanding the nature of this condition can help in seeking appropriate support and treatment.
Causes & Symptoms
Clinical Causes: Prolonged use of psychoactive substances such as alcohol, sedatives, stimulants, or other drugs that alter brain chemistry. Repeated episodes of intoxication and withdrawal increasing neurological vulnerability. Combination of multiple substances (poly-drug use) intensifying the risk. Pre-existing mental health conditions that predispose individuals to substance misuse. Environmental factors, including stress and social influences, contributing to ongoing abuse.
Key Symptoms: Memory impairment, especially affecting recent events or new information. Difficulty learning new skills or retaining new details. Confusion or disorientation regarding time or place. Reduced cognitive functioning impacting daily activities. Possible mood disturbances such as irritability, anxiety, or depression. Behavioral changes including withdrawal from social activities or responsibilities. Physical signs related to substance abuse like tremors, drowsiness, or agitation.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment that includes reviewing the patient’s medical history, substance use patterns, and cognitive function. Neuropsychological testing may be conducted to evaluate memory and other cognitive abilities. Brain imaging or other diagnostic tests might be utilized to rule out other neurological conditions or injuries. A mental health professional considers the duration and severity of substance use and associated cognitive deficits to confirm the diagnosis of F19.16.
Treatment Protocols: Treatment typically encompasses a combination of approaches tailored to the individual’s needs: - Substance detoxification and withdrawal management when necessary. - Psychotherapy, including cognitive-behavioral therapy (CBT), to address both substance dependence and cognitive deficits. - Medications may be prescribed to manage symptoms or co-occurring mental health issues. - Support groups and community programs to encourage ongoing recovery and prevent relapse. - Cognitive rehabilitation techniques designed to improve memory and executive functioning. - Continuous monitoring and follow-up to adjust treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is F19.16 a billable ICD-10 code?
Yes, F19.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.16?
Clinical documentation must specify the nature of Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference